Katinka van de Ven
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Katinka van de Ven has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Kyle J. D. Mulrooney
University of New England
9 shared publications - Alison Ritter
Drug Policy Modelling Program, Social Policy Research Centre UNSW Sydney Sydney Australia
6 shared publications Jim McVeigh
4 shared publications- Matthew Dunn
School of Health and Social Development Deakin University Geelong Australia
3 shared publications Jenny Chalmers
Drug Policy Modelling Program, Social Policy Research Centre University of NSW Sydney NSW Australia
2 shared publications- Jim McVeigh
Manchester Metropolitan University
2 shared publications
Latest Publications
- Open Access
- 6 June 2026
- Published by Elsevier in International Journal of Drug Policy
- Vol. 155, 105380
Psychoactive drug use among athletes: motives and risk factors beyond sports performance – A scoping review
- 6 June 2026
- Published by Elsevier in International Journal of Drug Policy
- Vol. 155, 105380
Open AccessPsychoactive drug use among athletes: motives and risk factors beyond sports performance – A scoping review
- 12 February 2026
- Published by Wiley in Health Promotion Journal of Australia
- Vol. 37 (2) , e70161
Alcohol Use, Demographics and Mental Health of Women Using a Digital Peer Support Program
Background: Risky alcohol use is rising among some groups of women. This trend is concerning given their vulnerability to alcohol‐related harm arising from biological and socio‐cultural factors. Stigma, caregiving responsibilities, and limited childcare often reduce access to traditional treatment. Concurrently, population‐wide increases in psychological distress are driving demand for support services. Digital interventions for alcohol use like the Daybreak app may offer accessible, anonymous early intervention, helping to overcome barriers and meet unmet needs. Methods: Data were analysed from 41 052 women who registered for the Daybreak app between 2019 and 2024. Participants completed demographic questions, the Alcohol Use Disorders Identification Test–Consumption (AUDIT‐C), and the Kessler Psychological Distress Scale (K10) online. Results: AUDIT‐C scores differed significantly by age, with the highest scores among women aged 35–54 years and the lowest among those aged 75 and over. Overall, 97.7% of participants scored above the recommended cut‐off for high‐risk drinking, with rates remaining stable over time. Additionally, 96.6% met the threshold for potential alcohol dependence. Based on K10 scores, 57.8% of participants reported high or very high psychological distress. Conclusion: By reaching women with high‐risk drinking and psychological distress, the Daybreak app may offer accessible support outside traditional services. Daybreak's growing use, especially among younger women, indicates that continued investment and broader promotion of digital interventions may be warranted.
- 12 February 2026
- Published by Wiley in Health Promotion Journal of Australia
- Vol. 37 (2) , e70161
Alcohol Use, Demographics and Mental Health of Women Using a Digital Peer Support Program
Background: Risky alcohol use is rising among some groups of women. This trend is concerning given their vulnerability to alcohol‐related harm arising from biological and socio‐cultural factors. Stigma, caregiving responsibilities, and limited childcare often reduce access to traditional treatment. Concurrently, population‐wide increases in psychological distress are driving demand for support services. Digital interventions for alcohol use like the Daybreak app may offer accessible, anonymous early intervention, helping to overcome barriers and meet unmet needs. Methods: Data were analysed from 41 052 women who registered for the Daybreak app between 2019 and 2024. Participants completed demographic questions, the Alcohol Use Disorders Identification Test–Consumption (AUDIT‐C), and the Kessler Psychological Distress Scale (K10) online. Results: AUDIT‐C scores differed significantly by age, with the highest scores among women aged 35–54 years and the lowest among those aged 75 and over. Overall, 97.7% of participants scored above the recommended cut‐off for high‐risk drinking, with rates remaining stable over time. Additionally, 96.6% met the threshold for potential alcohol dependence. Based on K10 scores, 57.8% of participants reported high or very high psychological distress. Conclusion: By reaching women with high‐risk drinking and psychological distress, the Daybreak app may offer accessible support outside traditional services. Daybreak's growing use, especially among younger women, indicates that continued investment and broader promotion of digital interventions may be warranted.
- 28 November 2025
- Published by Taylor & Francis
- p. 1-11
Reflecting on the current human enhancement drugs categorisation and new directions to consider
The recognition of human enhancement drugs (HEDs) as a distinct categorisation of substances is a relatively recent phenomenon. HEDs are currently divided into six sub-categories based on their reason for use. Specifically, drugs used to enhance: (1) the structure and function of muscle; (2) weight loss; (3) the appearance of the skin and hair; (4) sexual function and behaviour; (5) cognitive function; and (6) mood and social behaviour. While this provides a useful framework for describing the different types of HEDs, this categorisation would benefit from further development and refinement. Several complexities regarding HEDs were highlighted in the initial categorisation but were not fully explored; for instance, the six categories are not mutually exclusive, some substances are not solely HEDs but may also be prescribed for therapeutic purposes, and psychoactive drugs may also have enhancing effects. The issue is further complicated by the fact that there may not be scientific evidence to support a specific reason for the use of a substance. However, that is not seen as a barrier by consumers, particularly those looking to enhance cognition or sexual performance. This chapter revisits the HED taxonomy, reflect on the issues associated with HED categorisation, and explore the next steps in how we can better understand the use of these substances.
- 28 November 2025
- Published by Taylor & Francis
- p. 1-11
Reflecting on the current human enhancement drugs categorisation and new directions to consider
The recognition of human enhancement drugs (HEDs) as a distinct categorisation of substances is a relatively recent phenomenon. HEDs are currently divided into six sub-categories based on their reason for use. Specifically, drugs used to enhance: (1) the structure and function of muscle; (2) weight loss; (3) the appearance of the skin and hair; (4) sexual function and behaviour; (5) cognitive function; and (6) mood and social behaviour. While this provides a useful framework for describing the different types of HEDs, this categorisation would benefit from further development and refinement. Several complexities regarding HEDs were highlighted in the initial categorisation but were not fully explored; for instance, the six categories are not mutually exclusive, some substances are not solely HEDs but may also be prescribed for therapeutic purposes, and psychoactive drugs may also have enhancing effects. The issue is further complicated by the fact that there may not be scientific evidence to support a specific reason for the use of a substance. However, that is not seen as a barrier by consumers, particularly those looking to enhance cognition or sexual performance. This chapter revisits the HED taxonomy, reflect on the issues associated with HED categorisation, and explore the next steps in how we can better understand the use of these substances.
- 28 November 2025
- Published by Taylor & Francis
Human Enhancement Drugs
Offering an in-depth, multidisciplinary exploration of drugs used to enhance the structure and function of muscle, weight loss, the appearance of the skin and hair, sexual function and behaviour, cognitive function, and mood and social behaviour, this book builds on the first volume by investigating the categorising of these drugs, new populations, emerging issues and harm reduction strategies, advancing the global understanding of human enhancement. This volume provides fresh insights into sports doping as well as under-researched areas, offering practical and theoretical knowledge for academics, practitioners and policymakers. Key features include a global perspective, contributions from leading experts, and coverage of novel topics such as microdosing, rural drug use and sexualised drug use. By bridging theory and practice, the book equips readers with the knowledge and tools to address the complexities of HED use, including harm reduction and policy challenges. Human Enhancement Drugs: Volume Two is designed for academics, students (undergraduate and postgraduate), health professionals and anti-doping officials. This book is ideal for public health, sports science, criminology, sociology and law modules, among others. Its interdisciplinary and practice-based approach ensures relevance across diverse educational and professional settings.
- 28 November 2025
- Published by Taylor & Francis
Human Enhancement Drugs
Offering an in-depth, multidisciplinary exploration of drugs used to enhance the structure and function of muscle, weight loss, the appearance of the skin and hair, sexual function and behaviour, cognitive function, and mood and social behaviour, this book builds on the first volume by investigating the categorising of these drugs, new populations, emerging issues and harm reduction strategies, advancing the global understanding of human enhancement. This volume provides fresh insights into sports doping as well as under-researched areas, offering practical and theoretical knowledge for academics, practitioners and policymakers. Key features include a global perspective, contributions from leading experts, and coverage of novel topics such as microdosing, rural drug use and sexualised drug use. By bridging theory and practice, the book equips readers with the knowledge and tools to address the complexities of HED use, including harm reduction and policy challenges. Human Enhancement Drugs: Volume Two is designed for academics, students (undergraduate and postgraduate), health professionals and anti-doping officials. This book is ideal for public health, sports science, criminology, sociology and law modules, among others. Its interdisciplinary and practice-based approach ensures relevance across diverse educational and professional settings.
- 1 October 2025
- Published by Springer Nature
- p. 305-328
‘The Fittest on Earth’: Performance and Image Enhancing Drugs Use Within UK CrossFit Communities
- 1 October 2025
- Published by Springer Nature
- p. 305-328
‘The Fittest on Earth’: Performance and Image Enhancing Drugs Use Within UK CrossFit Communities
- Open Access
- 8 June 2025
- Published by Wiley in Drug and Alcohol Review
- Vol. 44 (5) , 1556-1563
Assessing the Processes and Experiences of Using and Implementing a Routine Data Collection System at Two Aboriginal Alcohol and Other Drug Residential Services Located in Rural Queensland
Introduction: Routine data collection in alcohol and other drug (AOD) treatment services is essential for continuous quality improvement, yet its implementation in Aboriginal residential services remains challenging. This study evaluates the processes and experiences of implementing a routine data collection system at two Aboriginal AOD residential rehabilitation services in rural Queensland, both of which operate under a family‐centric model of care.Methods: A participatory evaluation approach was used, engaging staff and clients to co‐design and implement data collection tools. The study progressed in two phases. Phase 1 focused on developing data collection tools. Phase 2 involved implementing these tools to assess client experiences and outcomes. Data collection included the Aboriginal Resilience and Recovery Questionnaire, WHOQOL‐BREF and other validated AOD outcome measures, with surveys conducted at multiple time points.Results: Staff engagement was crucial to successful implementation, though maintaining involvement over time proved challenging. Logistical and financial barriers, including IT infrastructure limitations and staff turnover, impacted sustainability. Although post‐treatment follow‐up was difficult, many clients found the outcome survey to be a valuable therapeutic tool. The client experience survey led to direct service improvements, whereas outcome monitoring required additional refinement for long‐term feasibility.Discussion and Conclusions: Routine data collection can enhance service quality and client outcomes when embedded into clinical practice. However, sustainability depends on staff buy‐in, streamlined processes and dedicated resources. Addressing barriers to post‐treatment follow‐up and ensuring data collection remains relevant to both staff and clients will be essential for ongoing implementation.
- 8 June 2025
- Published by Wiley in Drug and Alcohol Review
- Vol. 44 (5) , 1556-1563
Open AccessAssessing the Processes and Experiences of Using and Implementing a Routine Data Collection System at Two Aboriginal Alcohol and Other Drug Residential Services Located in Rural Queensland
Introduction: Routine data collection in alcohol and other drug (AOD) treatment services is essential for continuous quality improvement, yet its implementation in Aboriginal residential services remains challenging. This study evaluates the processes and experiences of implementing a routine data collection system at two Aboriginal AOD residential rehabilitation services in rural Queensland, both of which operate under a family‐centric model of care.Methods: A participatory evaluation approach was used, engaging staff and clients to co‐design and implement data collection tools. The study progressed in two phases. Phase 1 focused on developing data collection tools. Phase 2 involved implementing these tools to assess client experiences and outcomes. Data collection included the Aboriginal Resilience and Recovery Questionnaire, WHOQOL‐BREF and other validated AOD outcome measures, with surveys conducted at multiple time points.Results: Staff engagement was crucial to successful implementation, though maintaining involvement over time proved challenging. Logistical and financial barriers, including IT infrastructure limitations and staff turnover, impacted sustainability. Although post‐treatment follow‐up was difficult, many clients found the outcome survey to be a valuable therapeutic tool. The client experience survey led to direct service improvements, whereas outcome monitoring required additional refinement for long‐term feasibility.Discussion and Conclusions: Routine data collection can enhance service quality and client outcomes when embedded into clinical practice. However, sustainability depends on staff buy‐in, streamlined processes and dedicated resources. Addressing barriers to post‐treatment follow‐up and ensuring data collection remains relevant to both staff and clients will be essential for ongoing implementation.
- 24 February 2025
- Published by Elsevier in International Journal of Drug Policy
- Vol. 138, 104744
A scoping review of key domains for youth outcome measurement in alcohol and other drug treatment
- 24 February 2025
- Published by Elsevier in International Journal of Drug Policy
- Vol. 138, 104744
A scoping review of key domains for youth outcome measurement in alcohol and other drug treatment
- Open Access
- 17 September 2024
- Published by SAGE Publications in Crime, Media, Culture: An International Journal
- Vol. 21 (3) , 321-337
Problematising anabolic-androgenic steroids in Australian media: Violence, crime and disordered masculinity
As anabolic-androgenic steroid use has become more mainstream, so has media reporting on steroid-related problems and harms. The media is a particularly important site in shaping the social meanings of alcohol and other drug use, yet no research to date has focused on media representations of steroids and their effects. Informed by Bacchi’s post-structural method of problematisation analysis, we examine how the Australian news media problematises steroids and significant political effects produced by dominant problematisations. Australian news articles from 37 sources were electronically collected via the Factiva database during 2022, with 151 articles included in the final sample. In this article, we focus on the three most significant themes across the data. First, we analyse how steroid use is problematised in relation to alcohol use in public and men’s ‘natural’inclination to violence. We then explore how steroid supply and distribution is problematised as a matter of organised crime. Lastly, we analyse how steroid using subjects are constituted in relation to disordered masculinity and psychopathology, producing a range of negative material effects for consumers. We conclude by arguing that such media reporting is active in the normalisation of policies and interventions focused on pathologizing or criminalising individuals. As a result, the need for other credible policy responses, such as strategies for addressing steroid-related stigma, harm reduction policies and decriminalisation, tend to be ignored.
- 17 September 2024
- Published by SAGE Publications in Crime, Media, Culture: An International Journal
- Vol. 21 (3) , 321-337
Open AccessProblematising anabolic-androgenic steroids in Australian media: Violence, crime and disordered masculinity
As anabolic-androgenic steroid use has become more mainstream, so has media reporting on steroid-related problems and harms. The media is a particularly important site in shaping the social meanings of alcohol and other drug use, yet no research to date has focused on media representations of steroids and their effects. Informed by Bacchi’s post-structural method of problematisation analysis, we examine how the Australian news media problematises steroids and significant political effects produced by dominant problematisations. Australian news articles from 37 sources were electronically collected via the Factiva database during 2022, with 151 articles included in the final sample. In this article, we focus on the three most significant themes across the data. First, we analyse how steroid use is problematised in relation to alcohol use in public and men’s ‘natural’inclination to violence. We then explore how steroid supply and distribution is problematised as a matter of organised crime. Lastly, we analyse how steroid using subjects are constituted in relation to disordered masculinity and psychopathology, producing a range of negative material effects for consumers. We conclude by arguing that such media reporting is active in the normalisation of policies and interventions focused on pathologizing or criminalising individuals. As a result, the need for other credible policy responses, such as strategies for addressing steroid-related stigma, harm reduction policies and decriminalisation, tend to be ignored.
- 19 July 2023
- Published by SAGE Publications in Trauma, Violence, & Abuse
- Vol. 25 (2) , 1484-1495
The Association Between the Nonmedical use of Anabolic–Androgenic Steroids and Interpersonal Violence: A Meta-Analysis
The nonmedical use of anabolic–androgenic steroids (AAS) by athletes and the general population is a public health concern. One particular concern relates to the link between AAS use and violence. Although there is a growing body of research on the association between AAS and violence, results as to what the relationship is seem to be mixed. The aim of this meta-analysis is to improve our understanding of what the current evidence base indicates regarding the relationship between the use of AAS and interpersonal violence. In total, 14 studies with a total of 16 samples met the inclusion criteria, comprising a total sample size of 137,055 participants. The findings show that there is a significant association between AAS use and interpersonal violence ( r = .21 [95% confidence intervals (CI): 0.15, 0.27], p < .00001), although small. It is however unclear what the direction of this relationship is as almost all studies failed to demonstrate whether AAS use occurred prior or subsequent to the violent behavior. Risk of bias for most studies was moderate or high. Three potential moderators, AAS use via self-report or testing, interpersonal violence via self-report or criminal records of violent behavior, and proportion of males, were nonsignificant. Although a meta-analytic relationship between AAS use and interpersonal violence was found, it is unclear to what extent AAS causes violent acts. We need to carefully consider the role of mediating factors, and that the relationship between the two could be part of a broader context as opposed to AAS being the cause of violence.
- 19 July 2023
- Published by SAGE Publications in Trauma, Violence, & Abuse
- Vol. 25 (2) , 1484-1495
The Association Between the Nonmedical use of Anabolic–Androgenic Steroids and Interpersonal Violence: A Meta-Analysis
The nonmedical use of anabolic–androgenic steroids (AAS) by athletes and the general population is a public health concern. One particular concern relates to the link between AAS use and violence. Although there is a growing body of research on the association between AAS and violence, results as to what the relationship is seem to be mixed. The aim of this meta-analysis is to improve our understanding of what the current evidence base indicates regarding the relationship between the use of AAS and interpersonal violence. In total, 14 studies with a total of 16 samples met the inclusion criteria, comprising a total sample size of 137,055 participants. The findings show that there is a significant association between AAS use and interpersonal violence ( r = .21 [95% confidence intervals (CI): 0.15, 0.27], p < .00001), although small. It is however unclear what the direction of this relationship is as almost all studies failed to demonstrate whether AAS use occurred prior or subsequent to the violent behavior. Risk of bias for most studies was moderate or high. Three potential moderators, AAS use via self-report or testing, interpersonal violence via self-report or criminal records of violent behavior, and proportion of males, were nonsignificant. Although a meta-analytic relationship between AAS use and interpersonal violence was found, it is unclear to what extent AAS causes violent acts. We need to carefully consider the role of mediating factors, and that the relationship between the two could be part of a broader context as opposed to AAS being the cause of violence.
- 22 December 2022
- Published by Springer Nature in Monash Bioethics Review
- Vol. 41 (1) , 22-36
Human enhancement drugs and Armed Forces: an overview of some key ethical considerations of creating ‘Super-Soldiers’
There is a long history and growing evidence base that the use of drugs, such as anabolic-androgenic steroids, to enhance human performance is common amongst armed forces, including in Australia. We should not be surprised that this might have occurred for it has long been predicted by observers. It is a commonplace of many recent discussion of the future of warfare and future military technology to proclaim the imminent arrival of Super Soldiers, whose capacities are modified via drugs, digital technology and genetic engineering, in ways that increase their performance exponentially. This is what some observers have referred to as the “Gladiator Model” wherein the aim is to create soldiers able to perform feats of which ordinary citizens are not capable. One key aspect of this “gladiator project” is the use of illicit drugs to enhance performance. Could we use drugs, such as steroids or amphetamines, to enhance performance? Should we use such drugs? In this paper we explore the ethics of creating Super Soldiers, and raise issues of consent, coercion and the extent to which such use is permitted or condemned by just war theory. We conclude that much will depend on the extent to which such use is harmful to the soldiers themselves and this is still an open question.
- 22 December 2022
- Published by Springer Nature in Monash Bioethics Review
- Vol. 41 (1) , 22-36
Human enhancement drugs and Armed Forces: an overview of some key ethical considerations of creating ‘Super-Soldiers’
There is a long history and growing evidence base that the use of drugs, such as anabolic-androgenic steroids, to enhance human performance is common amongst armed forces, including in Australia. We should not be surprised that this might have occurred for it has long been predicted by observers. It is a commonplace of many recent discussion of the future of warfare and future military technology to proclaim the imminent arrival of Super Soldiers, whose capacities are modified via drugs, digital technology and genetic engineering, in ways that increase their performance exponentially. This is what some observers have referred to as the “Gladiator Model” wherein the aim is to create soldiers able to perform feats of which ordinary citizens are not capable. One key aspect of this “gladiator project” is the use of illicit drugs to enhance performance. Could we use drugs, such as steroids or amphetamines, to enhance performance? Should we use such drugs? In this paper we explore the ethics of creating Super Soldiers, and raise issues of consent, coercion and the extent to which such use is permitted or condemned by just war theory. We conclude that much will depend on the extent to which such use is harmful to the soldiers themselves and this is still an open question.